DRHP Status : Not Filed
P&L Statement | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Revenue | 2431 | 2795 | 3037 | 3069 |
Cost of Material Consumed | 1149 | 1901 | 1923 | 1697 |
Gross Margins | 52.74 | 31.99 | 36.68 | 44.71 |
Change in Inventory | 120 | -262 | 18 | 137 |
Employee Benefit Expenses | 211 | 219 | 202 | 219 |
Other Expenses | 494 | 580 | 514 | 574 |
EBITDA | 457 | 357 | 380 | 442 |
OPM | 18.8 | 12.77 | 12.51 | 14.4 |
Other Income | -120 | 87 | 93 | 108 |
Finance Cost | 65 | 45 | 46 | 39 |
D&A | 112 | 90 | 87 | 89 |
EBIT | 345 | 267 | 293 | 353 |
EBIT Margins | 14.19 | 9.55 | 9.65 | 11.5 |
PBT | 160 | 308 | 339 | 422 |
PBT Margins | 6.58 | 11.02 | 11.16 | 13.75 |
Tax | 93 | 89 | 97 | 90 |
PAT | 67 | 219 | 242 | 332 |
NPM | 2.76 | 7.84 | 7.97 | 10.82 |
EPS | 31.46 | 102.82 | 113.62 | 155.87 |
Financial Ratios |
2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Operating Profit Margin | 18.8 | 12.77 | 12.51 | 14.4 |
Net Profit Margin | 2.76 | 7.84 | 7.97 | 10.82 |
Earning Per Share (Diluted) | 31.46 | 102.82 | 113.62 | 155.87 |
Assets | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Fixed Assets | 640 | 602 | 698 | 687 |
CWIP | 83 | 119 | 150 | 138 |
Investments | 711 | 899 | 1464 | 2333 |
Trade Receivables | 721 | 785 | 758 | 903 |
Inventory | 356 | 641 | 689 | 525 |
Other Assets | 753 | 798 | 373.5 | 571 |
Total Assets | 3264 | 3844 | 4132.5 | 5157 |
Liabilities | 2021 | 2022 | 2023 | 2024 |
---|---|---|---|---|
Share Capital | 21.3 | 21.3 | 21.3 | 21.3 |
FV | 10 | 10 | 10 | 10 |
Reserves | 1931 | 2199 | 2896 | 3973 |
Borrowings | 654 | 679 | 559 | 363 |
Trade Payables | 373 | 818 | 439 | 477 |
Other Liabilities | 284.7 | 126.7 | 217.2 | 322.7 |
Total Liabilities | 3264 | 3844 | 4132.5 | 5157 |
Name | Holding |
---|---|
K.K.Modi Investment And Financial Services | 43.87% |
U.P. State Industrial Development Corporation | 9.45% |
Rajputana Developers Limited | 8.89% |
APMS Investment Fund Limited (FII) | 6.81% |
Modi Industries Limited | 5.08% |
Others | 25.9% |
​Indofil Industries Limited, established over six decades ago, is a prominent player in the agricultural chemicals sector. Headquartered in Mumbai, India, the company operates with a vision to focus on specific opportunities, drive growth, and enhance value for its customers.
Business Divisions:
Agricultural Chemicals: Indofil offers a comprehensive range of products, including insecticides, fungicides, bactericides, herbicides, acaricides, surfactants, and plant growth regulators. The company is driven by the "Crop Care Concept," aiming to improve the well-being of farmers in India and globally. ​
Specialty & Performance Chemicals: Under the Indofil Innovative Solutions division, the company provides innovative products for industries such as leather, textiles, paints, plastics, and construction chemicals.
Global Presence:
Indofil has a significant international footprint, exporting to over 120 countries. It is recognized as a leading supplier of Mancozeb formulations, with subsidiary offices in Amsterdam, Brazil, Bangladesh, Shanghai, and the Philippines, among others. The company also maintains representative offices in Costa Rica and Sri Lanka, facilitating its global operations.
Manufacturing and Quality Standards:
The company operates state-of-the-art manufacturing facilities in Dahej, Gujarat, and Thane, Maharashtra. These facilities are ISO 9001, ISO 14001, and OHSAS 18001 certified, ensuring adherence to high-quality and environmental standards. The processes are fully automated, incorporating advanced equipment to maintain safety and efficiency. ​
Leadership:
Indofil's management is led by Chairperson and Managing Director Dr. Bina Modi, who brings extensive experience and a commitment to excellence. The board includes Executive Director Ms. Charu Modi and Non-Executive Director Mr. Samir Kumar Modi, among others, guiding the company's strategic direction
Strengths:
Robust Financial Performance: In the fiscal year 2024, Indofil reported revenues of ₹3,118 crore, achieving a 45% year-over-year growth in Profit After Tax (PAT). ​
Strategic Investments: The company holds substantial investments, including 6,545,020 shares in Godfrey Philips India Ltd., valued at approximately ₹5,389.8 crore as of May 2024. This holding enhances Indofil's intrinsic value per share.
Industry Growth Potential: The global agrochemical market is projected to grow at a compound annual growth rate (CAGR) of 3.9% between 2024 and 2030, positioning Indofil to benefit from increased demand.
Global Presence: With operations in over 90 countries, Indofil's extensive distribution network positions it to capture a significant share of the expanding global agrochemical market. ​
Weaknesses:
Liquidity Concerns: Unlisted shares inherently have lower liquidity compared to listed counterparts, potentially making it challenging for investors to buy or sell shares promptly. ​
Valuation Discrepancies: Indofil's unlisted shares are trading at a discount compared to their intrinsic value, partly due to internal family disputes affecting investor confidence.
Absence of IPO Plans: The lack of immediate plans for an Initial Public Offering (IPO) limits potential exit strategies for investors, contributing to the current undervaluation of shares. ​
Price Volatility: The unlisted nature of the shares can lead to higher price volatility due to limited trading activity and market speculation.